Source: European Medicines Agency (EU) Revision Year: 2022 Publisher: Novartis Europharm Limited, Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland
EXJADE 90 mg granules in sachet.
EXJADE 180 mg granules in sachet.
EXJADE 360 mg granules in sachet.
Pharmaceutical Form |
---|
Granules in sachet (granules). White to almost white granules. |
EXJADE 90 mg granules: Each sachet contains 90 mg deferasirox.
EXJADE 180 mg granules: Each sachet contains 180 mg deferasirox.
EXJADE 360 mg granules: Each sachet contains 360 mg deferasirox.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Deferasirox |
Deferasirox is an orally active chelator that is highly selective for iron (III). It is a tridentate ligand that binds iron with high affinity in a 2:1 ratio. Deferasirox promotes excretion of iron, primarily in the faeces. |
List of Excipients |
---|
Cellulose, microcrystalline |
Sachets of polyethylene terephthalate (PET)/Aluminium/polyethylene (PE) foil.
Unit packs containing 30 sachets.
Novartis Europharm Limited, Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland
EXJADE 90 mg granules: EU/1/06/356/020
EXJADE 180 mg granules: EU/1/06/356/021
EXJADE 360 mg granules: EU/1/06/356/022
Date of first authorisation: 28 August 2006
Date of latest renewal: 18 April 2016
Drug | Countries | |
---|---|---|
EXJADE | Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.